Semler Scientific Inc (SMLR)
31.79
-0.84
(-2.57%)
USD |
NASDAQ |
Jul 05, 16:00
31.53
-0.26
(-0.82%)
After-Hours: 20:00
Semler Scientific Cash from Financing (Quarterly): 0.011M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.011M |
| December 31, 2023 | -3.236M |
| September 30, 2023 | -0.051M |
| June 30, 2023 | -1.975M |
| March 31, 2023 | -0.146M |
| December 31, 2022 | 0.075M |
| September 30, 2022 | -2.025M |
| June 30, 2022 | -2.844M |
| March 31, 2022 | -0.143M |
| December 31, 2021 | -0.041M |
| September 30, 2021 | 0.009M |
| June 30, 2021 | 0.036M |
| March 31, 2021 | 0.009M |
| December 31, 2020 | 0.056M |
| September 30, 2020 | 0.104M |
| June 30, 2020 | 0.067M |
| March 31, 2020 | 0.003M |
| December 31, 2019 | -3.946M |
| September 30, 2019 | 0.016M |
| June 30, 2019 | -2.656M |
| March 31, 2019 | 0.013M |
| December 31, 2018 | -1.459M |
| September 30, 2018 | 0.145M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.133M |
| March 31, 2018 | -0.58M |
| December 31, 2017 | 0.621M |
| September 30, 2017 | 0.014M |
| June 30, 2017 | 0.103M |
| March 31, 2017 | 0.444M |
| December 31, 2016 | 0.262M |
| September 30, 2016 | 0.095M |
| June 30, 2016 | 0.278M |
| March 31, 2016 | 2.20M |
| December 31, 2015 | 0.549M |
| September 30, 2015 | -2.073M |
| June 30, 2015 | 0.414M |
| March 31, 2015 | 0.498M |
| December 31, 2014 | 1.89M |
| September 30, 2014 | -0.103M |
| June 30, 2014 | -0.026M |
| March 31, 2014 | 8.024M |
| December 31, 2013 | -0.214M |
| September 30, 2013 | 1.547M |
| June 30, 2013 | 0.329M |
| March 31, 2013 | -0.026M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.946M
Minimum
Dec 2019
0.104M
Maximum
Sep 2020
-0.7379M
Average
0.003M
Median
Mar 2020
Cash from Financing (Quarterly) Benchmarks
| Predictive Oncology Inc | -0.1124M |
| Perspective Therapeutics Inc | 166.33M |
| Xtant Medical Holdings Inc | 5.179M |
| Asensus Surgical Inc | 0.811M |
| Catheter Precision Inc | -0.11M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.624M |
| Cash from Investing (Quarterly) | -0.081M |
| Free Cash Flow | 25.82M |
| Free Cash Flow Per Share (Quarterly) | 0.7122 |
| Free Cash Flow to Equity (Quarterly) | 5.543M |
| Free Cash Flow to Firm (Quarterly) | 5.543M |
| Free Cash Flow Yield | 10.41% |